What is BTCS's research and development capitalization?

BTCS (BTCS) reported research and development capitalization of $122.52K in Q4 2024.

What does research and development capitalization mean?

This represents the portion of research and development expenditures that are recorded as assets on the balance sheet rather than expensed immediately. It indicates the company's investment in long-term technological innovation and future product development capabilities.

BTCS BTCS Research And Development Capitalization

Research And Development Capitalization at other companies

IBT

IbottaIBTA

$22.65M-42.0%

BillionToOne, Inc. BLLN

$6.06M-47.2%

ESABESAB

$22.04M+7.2%

CorMedixCRMD

$36.28M—

Shattuck Labs, Inc.STTK

$29.42M-8.4%

Honeywell InternationalHON

$917M-3.1%

Other financials

Income statement

See full

Revenue$2.1M+27.1%

Gross profit$1.0M+743%

Net income-$69.2M-301%

EPS (diluted)-$1.43-66.3%

Balance sheet

See full

Cash & equivalents$285.0K+5.6%

Total equity$72.1M+251%

Total assets$129.0M+513%

Cash flow

See full

Operating cash flow-$1.7M+8.4%

CapEx$4.7K+616%

Free cash flow-$3.8M-325%

Valuation

See full

Market cap$55.25M+16.9%

P/S3.3×-3.0×

Profitability

See full

Gross margin17.1%+2.5pp

Operating margin-35,039.6%—

Net margin-503%—

FCF margin-59.4%-14.2pp

Returns & leverage

See full

Return on equity-184%—

Debt / equity2.1×—

Current ratio2.9×-40.5×

Where this comes from

Reported directly by BTCS in its filing.

Tagged under the XBRL concept BTCS:ResearchAndDevelopmentCapitalization.

The official record: BTCS’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BTCS's research and development capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BTCS's research and development capitalization?: BTCS (BTCS) reported research and development capitalization of $122.52K in Q4 2024.
What does research and development capitalization mean?: This represents the portion of research and development expenditures that are recorded as assets on the balance sheet rather than expensed immediately. It indicates the company's investment in long-term technological innovation and future product development capabilities.